FDA revised guidance documents for low-risk wellness products and clinical decision software, clarifying regulatory ...
The long-awaited publication of the high risk classification guidelines from the European Commission aims to offer more ...
The revised BSI Act implementing the European NIS2 Directive will come into force at the end of 2025. In parallel, the KRITIS ...
The medical device analyzes patient cancer risk without them needed to do any additional tests or imaging.
Making the effort to know the difference between what is voluntary and mandatory is key for any CTO or product lead Read more ...
The snowballing ability of artificial intelligence to trawl open data sets has some scientists worried about losing control ...
Scouring through corporate communications and broker research isn’t enough Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results